Skip to main content

Atopic Dermatitis

Atopic Dermatitis

Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices
NEA Approved Features
Itch is one of the most common—and distressing—symptoms of atopic dermatitis, and effectively treating it requires an understanding of the underlying pathology of the disease.
News
New research is illuminating the phenotypes of atopic dermatitis (AD) among racial subgroups, which could impact the efficacy of current and future therapies. In a recent study, researchers investigated the efficacy and safety of dupilumab among various racial subgroups.
Case Reports
A 28-year-old construction worker presented for evaluation of an itchy, spreading rash that had begun on his arms and legs.
Podcast
In this podcast, Jonathan I. Silverberg, MD, PhD, MPH, associate professor of dermatology, medical social sciences, and preventive medicine at Northwestern Feinberg School of Medicine, discusses translating the latest evidence on comorbidities in atopic dermatitis into practice.
NEA Approved Features
Research has barely scratched the surface of what we can learn about the relationships between immunity and inflammatory skin disease. A leading expert discusses the implications of emerging and future research on managing AD.
Podcast
Lindsay Chaney Strowd, MD, with Wake Forest School of Medicine, reviews some of the challenges of treating atopic dermatitis in the United States.
Podcast
Steven Feldman, MD, PhD, with Wake Forest School of Medicine, outlines ways dermatologists can improve adherence to medications among patients with atopic dermatitis in this short podcast.
NEA Approved Features
Eczema disproportionately affects patients with skin of color, who have different presentations and treatment concerns.
NEA Approved Features
In an interview with The Dermatologist, Dr Lio spoke about the association between AD and food allergy, the efficacy of elimination diets, and how he discusses diet with patients and caregivers.
Derm Q&A
The microbiome may be involved in the development of atopic dermatitis (AD) and may be promising for new therapeutic options. In an interview with The Dermatologist, Peter Lio, MD, discusses the latest evidence on the microbiome and AD.
Back to Top